Association of interleukin-18 gene single-nucleotide polymorphisms with susceptibility to inflammatory bowel disease

被引:37
作者
Aizawa, Y [1 ]
Sutoh, S [1 ]
Matsuoka, M [1 ]
Negishi, M [1 ]
Torii, A [1 ]
Miyakawa, Y [1 ]
Sugisaka, H [1 ]
Nakamura, M [1 ]
Toda, G [1 ]
机构
[1] Jikei Univ, Fac Gastroenterol & Hepatol, Dept Internal Med, Katsushika Ku,Sch Med,Div Gastroenterol & Hepatol, Tokyo 1258506, Japan
来源
TISSUE ANTIGENS | 2005年 / 65卷 / 01期
关键词
Crohn's disease; E-M algorithm; haplotype; inflammatory bowel disease; interleukin-18; single-nucleotide polymorphism; ulcerative colitis;
D O I
10.1111/j.1399-0039.2005.00336.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interleukin-18 (IL-18) is believed to be one of the most important cytokines in the pathogenesis of inflammatory bowel disease (IBD). The aim of the study was to clarify the significance of single-nucleotide polymorphisms (SNPs) at the 5'-end of the IL-18 gene in the development of IBD. DNA was obtained from peripheral blood of 99 patients with ulcerative colitis (UC), 79 patients with Crohn's disease (CD), and 102 healthy controls. All participants were Japanese. SNPs at -656G/T, -607C/A, -137G/C, +113T/G, and +127C/T were determined by means of direct sequencing, and a genetic association with IBD was examined. The frequencies of the G allele at +113 and the T allele at +127 were significantly higher in patients with CD and UC compared with controls. The differences in allelic frequencies were more striking in patients with CD than in patients with UC, and at position +127 than at position +113. The haplotype estimation, according to the E-M algorithm, suggested that TACGT is closely associated with IBD, especially with CD. It was concluded that SNPs at the 5'-end of IL-18 gene might be closely related to the etiology of IBD.
引用
收藏
页码:88 / 92
页数:5
相关论文
共 28 条
  • [1] Is nutrition an aetiological factor for inflammatory bowel disease?
    Cashman, KD
    Shanahan, F
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (06) : 607 - 613
  • [2] MAXIMUM LIKELIHOOD FROM INCOMPLETE DATA VIA EM ALGORITHM
    DEMPSTER, AP
    LAIRD, NM
    RUBIN, DB
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-METHODOLOGICAL, 1977, 39 (01): : 1 - 38
  • [3] Serum interleukin-18 concentrations in patients with inflammatory bowel disease
    Furuya, D
    Yagihashi, A
    Komatsu, M
    Masashi, N
    Tsuji, N
    Kobayashi, D
    Watanabe, N
    [J]. JOURNAL OF IMMUNOTHERAPY, 2002, 25 : S65 - S67
  • [4] Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation
    Giedraitis, V
    He, B
    Huang, WX
    Hillert, J
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2001, 112 (1-2) : 146 - 152
  • [5] The-295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease
    Glas, J
    Török, HP
    Unterhuber, H
    Radlmayr, M
    Folwaczny, C
    [J]. CLINICAL IMMUNOLOGY, 2003, 106 (03) : 197 - 200
  • [6] Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type I diabetes
    Ide, A
    Kawasaki, E
    Abiru, N
    Sun, F
    Kobayashi, M
    Fukushima, T
    Takahashi, R
    Kuwahara, H
    Kita, A
    Oshima, K
    Uotani, S
    Yamasaki, H
    Yamaguchi, Y
    Eguchi, K
    [J]. JOURNAL OF AUTOIMMUNITY, 2004, 22 (01) : 73 - 78
  • [7] Interleukin 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease
    Kanai, T
    Watanabe, M
    Okazawa, A
    Nakamaru, K
    Okamoto, M
    Naganuma, M
    Ishii, H
    Ikeda, M
    Kurimoto, M
    Hibi, T
    [J]. GASTROENTEROLOGY, 2000, 119 (06) : 1514 - 1523
  • [8] Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease
    Klein, W
    Tromm, A
    Griga, T
    Folwaczny, C
    Hocke, M
    Eitner, K
    Marx, M
    Duerig, N
    Epplen, JT
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (08) : 834 - 836
  • [9] Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc
    Kozaiwa, K
    Sugawara, K
    Smith, MF
    Carl, V
    Yamschikov, V
    Belyea, B
    McEwen, SB
    Moskaluk, CA
    Pizarro, TT
    Cominelli, F
    McDuffie, M
    [J]. GASTROENTEROLOGY, 2003, 125 (02) : 477 - 490
  • [10] Interleukin-18 promoter Polymorphisms in type 1 diabetes
    Kretowski, A
    Mironczuk, K
    Karpinska, A
    Bojaryn, U
    Kinalski, M
    Puchalski, Z
    Kinalska, I
    [J]. DIABETES, 2002, 51 (11) : 3347 - 3349